NCT02710526View on ClinicalTrials.gov

Phase II Pharmacokinetics Study of CAM2038

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 17, 2017

Study Completion Date

July 3, 2017

Conditions
Opioid Use DisorderChronic Pain
Interventions
DRUG

CAM2038

Long-Acting Subcutaneous Injectable Depot of Buprenorphine

Trial Locations (3)

35215

Parkway Medical, Birmingham

73112

The Rivus Wellness & Research Institute, Oklahoma City

08009

Hassman Research Institute, Berlin

Sponsors
All Listed Sponsors
lead

Braeburn Pharmaceuticals

INDUSTRY